HEPION PHARMACEUTICALS, INC. Cash and Cash Equivalents
HEPION PHARMACEUTICALS, INC. (HEPA) had Cash and Cash Equivalents of $13.92 million as of 2019-12-31, per its 10-K filed 2020-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2020-05-14
- 2019-12-31: Cash and Cash Equivalents, at Carrying Value $13.92M.
- 2019-09-30: Cash and Cash Equivalents, at Carrying Value $14.86M.
- 2019-06-30: Cash and Cash Equivalents, at Carrying Value $17.15M.
- 2019-03-31: Cash and Cash Equivalents, at Carrying Value $1.68M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2019-12-31 | $13.92M 10-K · filed 2020-05-14 |
| 2019-09-30 | $14.86M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $17.15M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.68M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.83M 10-K · filed 2020-05-14 |
| 2018-09-30 | $9.03M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $2.58M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $4.00M 10-Q · filed 2019-05-15 |
| 2017-12-31 | $5.95M 10-K · filed 2020-05-14 |
| 2017-06-30 | $12.98M 10-K · filed 2019-03-14 |
| 2016-06-30 | $7.40M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |